IE 11 is not supported. For an optimal experience visit our site on another browser.

Johnson & Johnson announces single-shot COVID-19 vaccine

03:33

Johnson & Johnson announced Friday that its single-dose COVID-19 vaccine is 66% effective overall in its prevention of moderate to severe disease and 72% effective in the U.S.